Why is Zymeworks, Inc. ?
- The company has been able to generate a Return on Equity (avg) of 7.29% signifying low profitability per unit of shareholders funds
- The company has declared negative results in Dec 25 after 4 consecutive negative quarters
- OPERATING CASH FLOW(Y) Lowest at USD -75.38 MM
- ROCE(HY) Lowest at -42.02%
- RAW MATERIAL COST(Y) Grown by 122.15% (YoY)
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 83.21%, its profits have risen by 23.3%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 5.55 times
Lowest at USD -75.38 MM
Lowest at -42.02%
Grown by 122.15% (YoY
Highest at -61.85 %
Lowest at USD 2.41 MM
Highest at USD 2.07 MM
Lowest at USD -44.27 MM
Lowest at -1,838.5 %
Lowest at USD -46.35 MM
Lowest at USD -44.16 MM
Lowest at USD -0.59
Here's what is working for Zymeworks, Inc.
Debtors Turnover Ratio
Depreciation (USD MM)
Here's what is not working for Zymeworks, Inc.
Net Sales (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Interest Paid (USD MM)
Net Sales (USD MM)
Interest Paid (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales






